M. Uzel Şener Et Al. , "Different approach to M descriptor for future staging of oligometastatic disease in SCLC: A cross-sectional survival analysis," Clinical and Translational Oncology , 2024
Uzel Şener, M. Et Al. 2024. Different approach to M descriptor for future staging of oligometastatic disease in SCLC: A cross-sectional survival analysis. Clinical and Translational Oncology .
Uzel Şener, M., Akın Kabalak, P., Kavurgacı, S., YILMAZ DEMİRCİ, N., Kızılgöz, D., YANIK, F., ... Ermin, S.(2024). Different approach to M descriptor for future staging of oligometastatic disease in SCLC: A cross-sectional survival analysis. Clinical and Translational Oncology .
Uzel Şener, Melahat Et Al. "Different approach to M descriptor for future staging of oligometastatic disease in SCLC: A cross-sectional survival analysis," Clinical and Translational Oncology , 2024
Uzel Şener, Melahat U. Et Al. "Different approach to M descriptor for future staging of oligometastatic disease in SCLC: A cross-sectional survival analysis." Clinical and Translational Oncology , 2024
Uzel Şener, M. Et Al. (2024) . "Different approach to M descriptor for future staging of oligometastatic disease in SCLC: A cross-sectional survival analysis." Clinical and Translational Oncology .
@article{article, author={Melahat Uzel Şener Et Al. }, title={Different approach to M descriptor for future staging of oligometastatic disease in SCLC: A cross-sectional survival analysis}, journal={Clinical and Translational Oncology}, year=2024}